SRS Sequential Sindilimab in Brain Metastasis of NSLSC

NCT04180501 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

25

Enrollment

OTHER

Sponsor class

Conditions

NSCLC Stage IV
Brain Metastases
SRS
Sintilimab

Interventions

COMBINATION_PRODUCT: SRS sequential sintilimab

Sponsor

Xiaorong Dong